M11.29
Other chondrocalcinosis, multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Other chondrocalcinosis, classified under ICD-10 code M11.29, refers to a condition characterized by the calcification of cartilage in multiple joints or sites within the body. This condition results from the abnormal deposition of calcium pyrophosphate dihydrate (CPPD) crystals within articular cartilage, leading to joint issues and discomfort. Unlike localized chondrocalcinosis, which affects specific joints, this form involves multiple locations, often signaling a more widespread metabolic or systemic issue.
Causes & Symptoms
Clinical Causes: Aging process leading to increased calcium crystal deposition in cartilage Genetic predisposition, including familial forms of calcification disorders Metabolic disorders such as hyperparathyroidism, hemochromatosis, or hypophosphatasia Joint trauma or injury that damages cartilage and promotes crystal formation Other underlying health conditions that disturb calcium or phosphate metabolism
Key Symptoms: Joint pain, especially during movement Swelling and inflammation in affected joints A sensation of stiffness, particularly after periods of inactivity Possible warmth and redness around inflamed joints Reduced joint mobility over time Periodic flare-ups that resemble gout in symptoms
Diagnostic & Treatment
Diagnosis Path: Diagnosis of multiple-site chondrocalcinosis involves a combination of clinical evaluation and imaging studies. Radiographs (X-rays) are commonly used to visualize calcified cartilage deposits across multiple joints. Synovial fluid analysis obtained via joint aspiration can detect calcium pyrophosphate crystals, confirming the presence of chondrocalcinosis. Blood tests may be conducted to identify underlying metabolic disorders contributing to the condition. A comprehensive medical history and physical examination help distinguish this condition from other joint problems such as osteoarthritis or gout.
Treatment Protocols: While there is no cure for chondrocalcinosis, treatment focuses on managing symptoms and preventing joint damage. Strategies may include:
Clinical Advice & FAQs
Billing Guidance
Is M11.29 a billable ICD-10 code?
Yes, M11.29 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.29?
Clinical documentation must specify the nature of Other chondrocalcinosis, multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference